Literature DB >> 9360178

Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging.

J T Keijer1, J J Bax, A C van Rossum, F C Visser, C A Visser.   

Abstract

In the past 20 years, radionuclide scintigraphy has proven to be a sensitive clinical tool in the assessment of myocardial perfusion abnormalities. Magnetic resonance imaging may also be used to study myocardial perfusion, but its potential value still has to emerge in the clinical setting. This review addresses the potential and achievements of both methods in clinical cardiology.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9360178     DOI： 10.1023/a:1005737725964

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN： 0167-9899


  130 in total

1.  Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography.

Authors:  S Kaul; P Kelly; J D Oliner; W P Glasheen; M W Keller; D D Watson
Journal:  J Am Coll Cardiol       Date:  1989-02       Impact factor: 24.094

2.  Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram.

Authors:  R Detrano; A Janosi; K P Lyons; G Marcondes; N Abbassi; V F Froelicher
Journal:  Am J Med       Date:  1988-04       Impact factor: 4.965

3.  Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis.

Authors:  D J Fintel; J M Links; J A Brinker; T L Frank; M Parker; L C Becker
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

4.  Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201)Thallium-SPECT and coronary angiography.

Authors:  J T Keijer; A C van Rossum; M J van Eenige; J J Bax; F C Visser; J J Teule; C A Visser
Journal:  J Magn Reson Imaging       Date:  2000-06       Impact factor: 4.813

5.  Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.

Authors:  B L Zaret; P Rigo; F J Wackers; R C Hendel; S H Braat; A S Iskandrian; B S Sridhara; D Jain; R Itti; A N Serafini
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

6.  Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ32014) and thallium.

Authors:  J A Leppo; D J Meerdink
Journal:  J Nucl Med       Date:  1990-01       Impact factor: 10.057

7.  Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.

Authors:  A J Sinusas; Q Shi; M T Saltzberg; P Vitols; D Jain; F J Wackers; B L Zaret
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

8.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA.

Authors:  H W Eichstaedt; R Felix; F C Dougherty; M Langer; W Rutsch; H Schmutzler
Journal:  Clin Cardiol       Date:  1986-11       Impact factor: 2.882

9.  Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA.

Authors:  T Nishimura; H Kobayashi; Y Ohara; N Yamada; K Haze; M Takamiya; K Hiramori
Journal:  AJR Am J Roentgenol       Date:  1989-10       Impact factor: 3.959

10.  Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis.

Authors:  A C Van Rossum; F C Visser; M J Van Eenige; M Sprenger; J Valk; F W Verheugt; J P Roos
Journal:  Am J Cardiol       Date:  1990-04-01       Impact factor: 2.778
View more
  1 in total

1.  Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent.

Authors:  Anthony Z Faranesh; Dara L Kraitchman; Elliot R McVeigh
Journal:  Magn Reson Med       Date:  2006-05       Impact factor: 4.668
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.